CANNOVUM CANNABIS AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.04 EUR | 0.00% |
|
-0.97% | +11.48% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.03M 1.13M 88.13M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
| Net cash position 2023 * | 1.1M 1.2M 93.68M | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 93.14% |
More Fundamentals
* Assessed data
More press releases
More news
| 1 day | +1.47% | ||
| 1 week | -0.97% | ||
| Current month | +3.03% | ||
| 1 month | +0.99% | ||
| 3 months | -28.17% | ||
| 6 months | -17.74% | ||
| Current year | +11.48% |
1 week
1.96
2.12
1 month
1.962.38
Current year
1.587.50
1 year
1.587.50
3 years
1.5828.00
5 years
1.5828.00
10 years
1.5828.00
| Managers | Title | Age | Since |
|---|---|---|---|
Pia Marten
FOU | Founder | - | 19/03/18 |
Klaus Madzia
IRC | Investor Relations Contact | - | - |
Paul Weber
SAM | Sales & Marketing | - | 31/12/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Udo Schmickler
CHM | Chairman | - | 30/11/19 |
Damian Adomeit
BRD | Director/Board Member | - | - |
Niklas Kornder
BRD | Director/Board Member | - | 30/09/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/06/24 | 2.04 | 0.00% | 0 |
| 03/06/24 | 2.04 | +3.03% | 8 |
| 31/05/24 | 1.98 | -2.94% | 303 |
| 30/05/24 | 2.04 | -1.92% | 0 |
| 29/05/24 | 2.08 | +0.97% | 709 |
Delayed Quote Deutsche Boerse AG, June 04, 2024 at 08:17 am
More quotes
Cannovum Cannabis AG is a Germany-based company. The Company engages as a wholesaler, importer and manufacturer of cannabis-based medicines and provide patients in Germany with medical cannabis. The Company focuses on the import of medical cannabis, medical-scientific education and distribution for facilitated access to cannabis-based therapies.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +11.48% | 1.13M | |
| +23.80% | 74.5B | |
| -1.28% | 24.24B | |
| +4.65% | 8.44B | |
| +9.92% | 8.45B | |
| -23.66% | 7.65B | |
| +12.64% | 5.24B | |
| +2.61% | 4.14B | |
| -6.90% | 3.95B | |
| +3.99% | 3.83B |
- Stock Market
- Equities
- 27N0 Stock